A new study published online today in The American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes. Researchers from the University of Pittsburgh School of Medicine, the Pitt Graduate School of Public Health, and Western Psychiatric Institute and Clinic of UPMC note that policymakers and insurers should consider generic-only coverage, rather than no gap coverage, to both conserve healthcare resources and improve health.
BLOOMFIELD, Conn. January 2, 2012 -- A randomized control study of 3,988 high-risk gastrointestinal, heart or lower respiratory patients by global health service company Cigna (NYSE:CI) found that prioritized, telephonic outreach by health plan case managers following hospital discharge reduced future readmissions by 22 percent. The results of the study are published in the December 2012 issue of the independent, peer-reviewed American Journal of Managed Care.
Translating Evidence-Based Research Into Value-Based Decisions
National Pharmaceutical Council Teams With AMGA, Premier to Develop Framework Published in American Journal of Managed Care
Diabetes Compendium
Oncology Compendium